Suchergebnisse - Portal für Medizinische Datenmodelle (MDM-Portal)

On-Study Form Bladder Cancer NCT00014534 CALGB-90104

- 21.08.15 - 1 Formular, 3 Itemgruppen, 61 Datenelemente, 1 Sprache

Itemgruppen: Muscle Invasive Bladder Disease: Prior Treatment Affecting the Bladder, Prior Therapy Date, CCRR MODULE

On-Study Form Bladder Cancer NCT00014534 CALGB-90104 NCT00014534 NCI Cooperative Group On-Study Form-Revised (CALGB-90104) Combination Chemotherapy in Treating Patients With Bladder Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=BE1B6E9C-942E-7181-E034-0003BA12F5E7

NCT00954174 On-Study - GOG-0261: Primary Ovarian Cancer - On Study Form - 3072737v1.0 - GOG-0261: Primary Ovarian Cancer - On Study Form

- 09.01.15 - 1 Formular, 5 Itemgruppen, 26 Datenelemente, 1 Sprache

Itemgruppen: HEADER MODULE, OVARIAN: DISEASE DESCRIPTION, OVARIAN: FINDINGS FROM PRIMARY SURGERY, OVARIAN: POST-OPERATIVE FINDINGS FOLLOWING PRIMARY SURGERY, COMMENTS

GOG-0261: Primary Ovarian Cancer - On Study Form Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=84C04E8A-314B-D474-E040-BB89AD435DDB

Bladder Cancer NCT00014534 On-Study - NCI Cooperative Group On-Study Form (CALGB-90104) - 2056020v3.0 - NCI Cooperative Group On-Study Form (CALGB-90104)

- 08.01.15 - 1 Formular, 6 Itemgruppen, 51 Datenelemente, 1 Sprache

Itemgruppen: MSKCC 00-138; CALGB-90104; ECOG, Form Administration, Disease Description for Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Disease: Prior Treatment Affecting the Bladder, Comments, CCRR MODULE

NCI Cooperative Group On-Study Form (CALGB-90104) Combination Chemotherapy in Treating Patients With Bladder Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A9C0279B-A154-2673-E034-0003BA12F5E7

Bladder Cancer NCT00445601 On-Study - S0337 Cystoscopy and Urine Markers Form - 2389143v1.0 - S0337 Cystoscopy and Urine Markers Form

- 20.09.21 - 1 Formular, 4 Itemgruppen, 25 Datenelemente, 1 Sprache

Itemgruppen: Header, Urine Markers, Cytoscopy, Comments

S0337 Cystoscopy and Urine Markers Form Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=FE26193B-C3C0-4C67-E034-0003BA3F9857

E1208 Hepatic On-Study Form NCT01004978

- 20.09.21 - 1 Formular, 9 Itemgruppen, 42 Datenelemente, 1 Sprache

Itemgruppen: Header Module, Patient demographics, Data amendment, History of Disease, Description of Current Disease, Pre-registration Evaluation, Child Pugh Classification, Baseline Abnormalities, Comments

E1208 Hepatic On-Study Form NCT01004978 Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=6FC737FA-1C8D-FBF0-E040-BB89AD4367A6

E2805 Renal Cell Carcinoma On-Study Form NCT00326898

- 20.09.21 - 1 Formular, 9 Itemgruppen, 50 Datenelemente, 1 Sprache

Itemgruppen: Header, Data amendment, Patient demographics, History of Disease, Description of Primary Disease, Description of Current Disease, Current Disease Symptoms, MUGA Scanning, Footer Module

E2805 Renal Cell Carcinoma On-Study Form NCT00326898 Sunitinib or Sorafenib in Treating Patients With Kidney Cancer That Was Removed By Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=053ADDEA-1681-66BC-E044-0003BA3F9857

Liver Cancer NCT01015833 On-Study - CALGB 80802 On-Study Form - 2940677v1.0 - CALGB 80802 On-Study Form

- 20.09.21 - 1 Formular, 6 Itemgruppen, 49 Datenelemente, 1 Sprache

Itemgruppen: Header Module, Patient Description, Prior Treatment, Required Lab Values, Child Pugh Classification, Footer Module

CALGB 80802 On-Study Form Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=73B6D8AE-497C-7324-E040-BB89AD43648A

On-Study - Bone Sarcoma - On-Study Form Newly Diagnosed Patients - 2291479v3.0 - Bone Sarcoma - On-Study Form Newly Diagnosed Patients

- 09.01.15 - 1 Formular, 5 Itemgruppen, 50 Datenelemente, 1 Sprache

Itemgruppen: CRF Header, Sarcoma: Form Administration, Bone Sarcoma: Disease Description, Bone Sarcoma: Prior Health History, Comments

Bone Sarcoma - On-Study Form Newly Diagnosed Patients Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=E208E9A0-535D-1660-E034-0003BA12F5E7

Lung Cancer NCT00113386 On-Study - RTOG-0412 I1: Initial Evaluation Form - 2288131v3.0 - RTOG-0412 I1: Initial Evaluation Form

- 27.09.21 - 1 Formular, 3 Itemgruppen, 23 Datenelemente, 1 Sprache

Itemgruppen: MODULE 1, PRE-TREATMENT CHACTERISTICS, LYMPH NODE ASSESSMENT

RTOG-0412 I1: Initial Evaluation Form Cisplatin and Docetaxel With or Without Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Newly Diagnosed Stage III Non-Small Cell Lung Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=E489FECB-49D8-0477-E034-0003BA3F9857

RTOG-0412 I1 Rev1: Initial Evaluation Form NCT00113386

- 20.09.21 - 1 Formular, 4 Itemgruppen, 44 Datenelemente, 1 Sprache

Itemgruppen: Header, PRE-TREATMENT CHACTERISTICS, LYMPH NODE ASSESSMENT, Comments

RTOG-0412 I1 Rev1: Initial Evaluation Form NCT00113386 Cisplatin and Docetaxel With or Without Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Newly Diagnosed Stage III Non-Small Cell Lung Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=ED65A888-399B-7059-E034-0003BA3F9857

ECOG-E1505 On-Study Form NCT00324805

- 20.09.21 - 1 Formular, 9 Itemgruppen, 56 Datenelemente, 1 Sprache

Itemgruppen: ECOG clinical trial administrative data, Data amendment, Pre-Treatment Characteristics, Patients registered to receive Regimen 4 (Pemetrexed/Cisplatin), Cardiac History, NSCLC Disease Description, Resection Information, Baseline Abnormalities, Comments

ECOG-E1505 On-Study Form NCT00324805 Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=078250FE-30E9-0714-E044-0003BA3F9857

RTOG-0617 I1: Radiation Therapy Oncology Group Phase III High-dose Vs Standard-dose Conformal XRT with Chemotherapy Initial Evaluation Form NCT00533949

- 20.09.21 - 1 Formular, 9 Itemgruppen, 82 Datenelemente, 1 Sprache

Itemgruppen: Clinical trial administrative data, PRE-TREATMENT CHACTERISTICS, Disease Staging, LYMPH NODE ASSESSMENT, carcinoma of the lung, Required Pretreatment Studies, PET Scan, Pretreatment Labs, Footer

RTOG-0617 I1: Radiation Therapy Oncology Group Phase III High-dose Vs Standard-dose Conformal XRT with Chemotherapy Initial Evaluation Form NCT00533949 High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=24AC693F-14F6-1842-E044-0003BA3F9857

Stichworte

Inhaltsverzeichnis

Ausgewählte Datenmodelle